BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 20554965)

  • 1. The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein.
    Wei C; Ni C; Song T; Liu Y; Yang X; Zheng Z; Jia Y; Yuan Y; Guan K; Xu Y; Cheng X; Zhang Y; Yang X; Wang Y; Wen C; Wu Q; Shi W; Zhong H
    J Immunol; 2010 Jul; 185(2):1158-68. PubMed ID: 20554965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residues Asn118 and Glu119 of hepatitis B virus X protein are critical for HBx-mediated inhibition of RIG-I-MAVS signaling.
    Wang F; Shen F; Wang Y; Li Z; Chen J; Yuan Z
    Virology; 2020 Jan; 539():92-103. PubMed ID: 31706164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection.
    Zhao G; An B; Zhou H; Wang H; Xu Y; Xiang X; Dong Z; An F; Yu D; Wang W; Bao S; Xie Q
    Int J Mol Med; 2012 Dec; 30(6):1498-504. PubMed ID: 22992810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.
    Lifland AW; Jung J; Alonas E; Zurla C; Crowe JE; Santangelo PJ
    J Virol; 2012 Aug; 86(15):8245-58. PubMed ID: 22623778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein.
    Jiang J; Tang H
    Protein Cell; 2010 Dec; 1(12):1106-17. PubMed ID: 21213104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
    Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation.
    Wang Y; Tong X; Ye X
    J Immunol; 2012 Dec; 189(11):5304-13. PubMed ID: 23087404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential.
    Oshiumi H; Sakai K; Matsumoto M; Seya T
    Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
    Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAR1 Stimulation by IFN-α Downregulates the Expression of MAVS via RNA Editing to Regulate the Anti-HBV Response.
    Li T; Yang X; Li W; Song J; Li Z; Zhu X; Wu X; Liu Y
    Mol Ther; 2021 Mar; 29(3):1335-1348. PubMed ID: 33279720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
    Lee Y; Song B; Park C; Kwon KS
    PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production.
    Wang R; Zhu Y; Lin X; Ren C; Zhao J; Wang F; Gao X; Xiao R; Zhao L; Chen H; Jin M; Ma W; Zhou H
    Autophagy; 2019 Jul; 15(7):1163-1181. PubMed ID: 30741586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium.
    Broquet AH; Hirata Y; McAllister CS; Kagnoff MF
    J Immunol; 2011 Feb; 186(3):1618-26. PubMed ID: 21187438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular Localizations of RIG-I, TRIM25, and MAVS Complexes.
    Sánchez-Aparicio MT; Ayllón J; Leo-Macias A; Wolff T; García-Sastre A
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
    Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
    J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS.
    He Z; Zhu X; Wen W; Yuan J; Hu Y; Chen J; An S; Dong X; Lin C; Yu J; Wu J; Yang Y; Cai J; Li J; Li M
    J Virol; 2016 Aug; 90(16):7219-7230. PubMed ID: 27252539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X gene impacts on the innate immunity and immune-tolerant phase in chronic hepatitis B virus infection.
    Chang KC; Chua HH; Chen YH; Tsuei DJ; Lee MH; Chiang CL; Jeng YM; Wu JF; Chen HL; Hsu HY; Ni YH; Chang MH
    Liver Int; 2022 Oct; 42(10):2154-2166. PubMed ID: 35762289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.